Taste Disorders
Conditions
Brief summary
Identify possible modulators for developing gustatory dysfunction among a sample of depressed Egyptian adults (age from 20 to 50 years old) under anti-depressants therapy ( for at least 3 months) using a questionnaire ( appendix) with a binary measuring unit (yes/no).
Detailed description
PECO * P Population: depressed Egyptian adults under anti-depressants therapy * E1 Exposure 1: commonly prescribed tricyclic antidepressants (Imipramine, Amitriptyline, Clomipramine HCL) * E2 Exposure 2: commonly prescribed Selective Serotonin Re-uptake inhibitors antidepressants ( Fluoxetine, Fluvoxamine, Sertraline, Citalopram, Paroxetine) * C control (non exposure) : non-pharmacological treatment ( psychotherapy) * O Outcome: Identify possible gustatory dysfunction modulators among these patients using a questionnaire ( appendix) with a binary measuring unit (yes/no).
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* • Depressed Egyptian adults under antidepressants therapy for at least 3 months/non-pharmacological treatment( psychotherapy) * Age from 20 to 50 years old
Exclusion criteria
* Antipsychotics * Hypnotics * Anticonvulsants * Ages other than the mentioned • Olfactory dysfunction * Chemosensory dysfunction
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Gustatory dysfunction modulators | during a period of 7months from February 2020 till August 2020 | -C.M will use an assessment questionnaire (appendix) to assess possible modulators for developing gustatory dysfunction including a number of short-term and long-term factors such as body mass, gender, age, local and systemic diseases, excessive alcohol drinking, drug dependence, smoking, state of oral hygiene, consumption of some foods or drugs |
Countries
Egypt